| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $187.20B | $158.76B | $152.77B |
| YoY Revenue Growth % | +17.9% | +3.9% | — |
| Gross Profit | $30.03B | $25.19B | — |
| Gross Margin % | 16.0% | 15.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $397.0M | $5.31B | $3.67B |
| Operating Margin % | 0.2% | 3.3% | 2.4% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $7.14B | $11.02B | $9.16B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.72B | $7.96B | $8.38B |
| Capital Expenditures (CapEx) | $8.42B | $7.14B | $6.87B |
| Free Cash Flow (FCF) | -$5.71B | $814.9M | $1.51B |
| FCF Margin % | -3.0% | 0.5% | 1.0% |
| Return on Invested Capital (ROIC %) | 0.8% | 10.1% | 2.6% |
| Cash & Short-Term Equivalents | $19.66B | $14.84B | — |
| Total Debt (Short + Long Term) | $25.83B | $23.73B | $42.90B |
| Total Stockholders' Equity | $32.18B | $32.79B | $88.00B |